DK138992C - Analogifremgangsmaade til fremstilling af 5,9beta-disubstituerede 2-tetrahydrofurfuryl-6,7-benzomorphaner eller syreadditionssalte heraf - Google Patents

Analogifremgangsmaade til fremstilling af 5,9beta-disubstituerede 2-tetrahydrofurfuryl-6,7-benzomorphaner eller syreadditionssalte heraf

Info

Publication number
DK138992C
DK138992C DK352875A DK352875A DK138992C DK 138992 C DK138992 C DK 138992C DK 352875 A DK352875 A DK 352875A DK 352875 A DK352875 A DK 352875A DK 138992 C DK138992 C DK 138992C
Authority
DK
Denmark
Prior art keywords
benzomorphanes
9beta
tetrahydrofurfuryl
disubstituted
preparation
Prior art date
Application number
DK352875A
Other languages
Danish (da)
English (en)
Other versions
DK352875A (da
DK138992B (da
Inventor
H Merz
A Langbein
G Walther
K Stockhaus
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of DK352875A publication Critical patent/DK352875A/da
Publication of DK138992B publication Critical patent/DK138992B/da
Application granted granted Critical
Publication of DK138992C publication Critical patent/DK138992C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK352875A 1974-08-05 1975-08-04 Analogifremgangsmaade til fremstilling af 5,9beta-disubstituerede 2-tetrahydrofurfuryl-6,7-benzomorphaner eller syreadditionssalte heraf DK138992C (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2437610A DE2437610A1 (de) 1974-08-05 1974-08-05 Neue 5,9-beta-disubstituierte 2-tetrahydrofurfuryl-6,7-benzomorphane, deren saeureadditionssalze, ihre verwendung als arzneimittel und verfahren zu deren herstellung

Publications (3)

Publication Number Publication Date
DK352875A DK352875A (da) 1976-02-06
DK138992B DK138992B (da) 1978-11-27
DK138992C true DK138992C (da) 1979-04-30

Family

ID=5922448

Family Applications (1)

Application Number Title Priority Date Filing Date
DK352875A DK138992C (da) 1974-08-05 1975-08-04 Analogifremgangsmaade til fremstilling af 5,9beta-disubstituerede 2-tetrahydrofurfuryl-6,7-benzomorphaner eller syreadditionssalte heraf

Country Status (27)

Country Link
US (1) US3982005A (es)
JP (1) JPS60358B2 (es)
AT (1) AT348140B (es)
BE (1) BE832099R (es)
BG (3) BG25088A3 (es)
CA (1) CA1049008A (es)
CH (7) CH613963A5 (es)
CS (1) CS189717B2 (es)
DD (1) DD122685A5 (es)
DE (1) DE2437610A1 (es)
DK (1) DK138992C (es)
ES (6) ES452767A1 (es)
FI (1) FI63229C (es)
FR (1) FR2320096A2 (es)
GB (1) GB1513950A (es)
HU (1) HU177952B (es)
IE (1) IE42216B1 (es)
IL (1) IL47860A (es)
LU (1) LU73138A1 (es)
NL (1) NL7509249A (es)
NO (1) NO143460C (es)
PH (1) PH13687A (es)
PL (3) PL99819B1 (es)
RO (3) RO67390A (es)
SE (1) SE425392B (es)
SU (3) SU591147A3 (es)
ZA (1) ZA754997B (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087532A (en) * 1974-03-09 1978-05-02 Boehringer Ingelheim Gmbh Analgesically useful 2-tetrahydrofurfuryl-5-lower alkyl-2-oxy-6,7-benzomorphans and salts thereof
GB1575009A (en) * 1976-06-21 1980-09-17 Acf Chemiefarma Nv 6,7-benzomorphan derivatives
DE2716687A1 (de) * 1977-04-15 1978-10-19 Boehringer Sohn Ingelheim 2'-hydroxy-2-(5-isoxazolylmethyl)-6,7benzomorphane, deren saeureadditionssalze und diese enthaltende arzneimittel
NL7804509A (nl) * 1978-04-26 1979-10-30 Acf Chemiefarma Nv Nieuwe 6,7-benzomorfanderivaten en zuuradditiezouten daarvan.
DE2828039A1 (de) * 1978-06-26 1980-01-10 Boehringer Sohn Ingelheim 2-(2-alkoxyethyl)-2'-hydroxy-6,7-benzomorphane deren saeureadditionssalze diese enthaltende arzneimittel und verfahren zu deren herstellung
JPS5636521A (en) * 1979-08-31 1981-04-09 Shin Etsu Chem Co Ltd Production of alkenyloxy group-containing organopolysiloxane
CL2008002199A1 (es) 2007-07-26 2009-10-23 Vitae Pharmaceuticals Inc Compuestos derivados de 1,3-oxazin-2-ona; composicion farmaceutica que comprende a dichos compuestos; y uso para tratar una enfermedad asociada con la actividad de la 11beta-hidroxiesteroide deshidrogenasa tipo 1 (11beta-hsd1) tales como dislipidemia, hiperlipidemia, hipertension, obesidad y enfermedad cardiovascular, entre otras.
CL2008003407A1 (es) 2007-11-16 2010-01-11 Boehringer Ingelheim Int Compuestos derivados de aril- y heteroarilcarbonilo de heterobiciclo sustituido; composicion farmaceutica; procedimiento de preparacion; y su uso en el tratamiento y/o prevencion de trastornos metabolicos, mediado por la inhibicion de la enzima hsd-1.
US8440658B2 (en) 2007-12-11 2013-05-14 Vitae Pharmaceuticals, Inc. Cyclic urea inhibitors of 11β-hydroxysteroid dehydrogenase 1
TW200934490A (en) 2008-01-07 2009-08-16 Vitae Pharmaceuticals Inc Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
US8592409B2 (en) 2008-01-24 2013-11-26 Vitae Pharmaceuticals, Inc. Cyclic carbazate and semicarbazide inhibitors of 11β-hydroxysteroid dehydrogenase 1
US8598160B2 (en) 2008-02-15 2013-12-03 Vitae Pharmaceuticals, Inc. Cycloalkyl lactame derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
US8138178B2 (en) 2008-05-01 2012-03-20 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
JP5538365B2 (ja) 2008-05-01 2014-07-02 ヴァイティー ファーマシューティカルズ,インコーポレイテッド 11β−ヒドロキシステロイドデヒドロゲナーゼ1の環状阻害剤
TW201004945A (en) 2008-05-01 2010-02-01 Vitae Pharmaceuticals Inc Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
US8765780B2 (en) 2008-05-13 2014-07-01 Boehringer Ingelheim International Gmbh Alicyclic carboxylic acid derivatives of benzomorphans and related scaffolds, medicaments containing such compounds and their use
CN102119160B (zh) 2008-07-25 2014-11-05 贝林格尔·英格海姆国际有限公司 11β-羟基类固醇脱氢酶1的环状抑制剂
WO2010010157A2 (en) 2008-07-25 2010-01-28 Boehringer Ingelheim International Gmbh INHIBITORS OF 11beta-HYDROXYSTEROID DEHYDROGENASE 1
MA33216B1 (fr) 2009-04-30 2012-04-02 Boehringer Ingelheim Int Inhibiteurs cycliques de la 11béta-hydroxysteroïde déshydrogénase 1
WO2011011123A1 (en) 2009-06-11 2011-01-27 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure
UY33001A (es) 2009-11-06 2011-05-31 Boehringer Ingelheim Int Derivados arilo y heteroarilcarbonilo de hexahidroindenopiridina y octahidrobenzoquinolina
JP5860042B2 (ja) 2010-06-16 2016-02-16 ヴァイティー ファーマシューティカルズ,インコーポレイテッド 置換5、6及び7員複素環、そのような化合物を含有する医薬及びそれらの使用
TWI537258B (zh) 2010-11-05 2016-06-11 百靈佳殷格翰國際股份有限公司 六氫茚并吡啶及八氫苯并喹啉之芳基-及雜環芳基羰基衍生物
US8735585B2 (en) 2011-08-17 2014-05-27 Boehringer Ingelheim International Gmbh Indenopyridine derivatives
KR20230112134A (ko) 2020-11-26 2023-07-26 신에쓰 가가꾸 고교 가부시끼가이샤 실온경화성 오르가노폴리실록산 조성물 및 물품 그리고 가수분해성 오르가노실란 화합물 및 그 제조 방법
EP4397695A1 (en) 2021-09-03 2024-07-10 Shin-Etsu Chemical Co., Ltd. Organopolysiloxane compound, room temperature-curable organopolysiloxane composition, and article

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE582575A (es) * 1958-09-22
US3700734A (en) * 1969-01-23 1972-10-24 Merck & Co Inc 2{40 -hydroxy-2,3,5-trimethyl-6,7-benzomorphan
DE2105743C3 (de) * 1971-02-08 1979-11-29 Boehringer Sohn Ingelheim 2-(Furylmethyl)- a -5,9-dialkyl -6,7benzomorphane, Verfahren zu ihrer Herstellung und deren Verwendung
CS166804B2 (es) * 1971-02-08 1976-03-29 Boehringer Sohn Ingelheim
DE2200596A1 (de) * 1972-01-07 1973-07-12 Boehringer Sohn Ingelheim N-(furyl-methyl)-2'-hydroxy-5-phenyl6,7-benzomorphane, deren saeureadditionssalze sowie verfahren zu deren herstellung
DE2217420C3 (de) * 1972-04-12 1981-03-12 C.H. Boehringer Sohn, 6507 Ingelheim N-Thienylmethyl-Heterocyclen, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zubereitungen
DE2229695A1 (de) * 1972-06-19 1974-01-31 Boehringer Sohn Ingelheim 2-(heteroaryl-methyl)-5,9 beta-dialkyl6,7-benzomorphane, deren saeureadditionssalze sowie verfahren zu deren herstellung

Also Published As

Publication number Publication date
SE7508789L (sv) 1976-02-10
BG25089A3 (en) 1978-07-12
ES452767A1 (es) 1977-10-01
DD122685A5 (es) 1976-10-20
FR2320096A2 (fr) 1977-03-04
FI63229C (fi) 1983-05-10
IE42216B1 (en) 1980-07-02
NO143460C (no) 1981-02-18
US3982005A (en) 1976-09-21
CH616420A5 (es) 1980-03-31
SE425392B (sv) 1982-09-27
RO72735A (ro) 1982-09-09
JPS60358B2 (ja) 1985-01-07
SU587858A3 (ru) 1978-01-05
CH615677A5 (es) 1980-02-15
ES452768A1 (es) 1977-10-01
ZA754997B (en) 1977-04-27
IL47860A0 (en) 1975-11-25
JPS5139673A (en) 1976-04-02
CA1049008A (en) 1979-02-20
ES452764A1 (es) 1977-10-16
PH13687A (en) 1980-09-01
RO67390A (ro) 1981-06-30
CH615680A5 (es) 1980-02-15
SU587859A3 (ru) 1978-01-05
CH615678A5 (es) 1980-02-15
RO72736A (ro) 1982-09-09
AT348140B (de) 1979-01-25
NO143460B (no) 1980-11-10
NO752731L (es) 1976-02-06
ATA523775A (de) 1978-06-15
NL7509249A (nl) 1976-02-09
CH616421A5 (es) 1980-03-31
ES452765A1 (es) 1977-10-16
DE2437610A1 (de) 1976-02-26
CH613963A5 (es) 1979-10-31
BE832099R (fr) 1976-02-04
IL47860A (en) 1979-01-31
FI63229B (fi) 1983-01-31
PL99838B1 (pl) 1978-08-31
ES452766A1 (es) 1977-10-01
GB1513950A (en) 1978-06-14
CS189717B2 (en) 1979-04-30
FR2320096B2 (es) 1978-09-01
DK352875A (da) 1976-02-06
AU8364675A (en) 1977-02-10
SU591147A3 (ru) 1978-01-30
BG25090A3 (en) 1978-07-12
BG25088A3 (en) 1978-07-12
IE42216L (en) 1976-02-05
HU177952B (en) 1982-02-28
FI752211A (es) 1976-02-06
LU73138A1 (es) 1977-04-13
CH615679A5 (es) 1980-02-15
DK138992B (da) 1978-11-27
ES452763A1 (es) 1977-10-01
PL99819B1 (pl) 1978-08-31
PL99816B1 (pl) 1978-08-31

Similar Documents

Publication Publication Date Title
DK138992C (da) Analogifremgangsmaade til fremstilling af 5,9beta-disubstituerede 2-tetrahydrofurfuryl-6,7-benzomorphaner eller syreadditionssalte heraf
DK140430B (da) Analogifremgangsmåde til fremstilling af 3-aryloxy-3-phenylpropylaminer eller syreadditionssalte heraf.
DK137188C (da) Analogifremgangsmaade til fremstilling af 2-tetrahydrofurfuryl-6,7-benzomorphaner eller syreadditionssalte heraf
DK139387C (da) Analogifremgangsmaade til fremstilling af apovincaminsyrederivater eller syreadditionssalte deraf
DK135842C (da) Analogifremgangsmade til fremstilling af 7-methoxy-6-thiatetracycliner eller syreadditionssalte deraf
DK441875A (da) Fremgangsmade til fremstilling af 2-phenyliminoimidazolidiner eller syreadditionssalte deraf
DK226476A (da) Fremgangsmade til fremstilling af propargyl-2-phenylamino-imidazoliner-(2) eller syreadditionssalte heraf
DK139724C (da) Analogifremgangsmaade til fremstilling af pyridobenzodiazepinoner eller salte heraf
DK137677C (da) Analogifremgangsmaade til fremstilling af basisk substitueredexanthinderivater eller syreadditionssalte heraf
DK139522C (da) Analogifremgangsmaade til fremstilling af 9-iminoalkylamino-erythromyciner eller syreadditionssalte deraf
DK137533C (da) Analogifremgangsmaade til fremstilling af 2-carbalkoxyaminobenzimidazolyl-5(6)-sulfonsyrephenylestere
DK137606C (da) Analogifremgangsmaade til fremstilling af substituerede 2-phenylamino-imidazoliner-(2) eller syreadditionssalte deraf
DK136821C (da) Analogifremgangsmaade til fremstilling af s-triazolo-(4,3-a)(1,5)-benzodiazepin-5-oner eller syreadditionssalte heraf
DK139517C (da) Analogifremgangsmaade til fremstilling af substituerede thiazol-2-carboxamider eller syreadditionssalte deraf
DK139574B (da) Analogifremgangsmåde til fremstilling af terpeno-phenoxy-alkylaminer eller syreadditionssalte deraf.
DK143197C (da) Analogifremgangsmaade til fremstilling af 5,7-dihydroxy-tetrahydroisoquinoliner eller farmaceutisk acceptable syreadditionssalte deraf
DK209275A (da) Fremgangsmade til fremstilling af 2,3-polymethylen-5-sulfamoylbenzoesyreforbindelser
DK135500C (da) Fremgangsmade til fremstilling af alfa1-tert.butylaminomethyl-4-hydroxy-m-xylen-alfa1,alfa3-diol eller syreadditionssalte deraf
DK134436C (da) Analogifremgangsmade til fremstilling af s(iv)-benzo-1,2,4-thiadiaziner eller syreadditionssalte deraf
DK138266B (da) Analogifremgangsmåde til fremstilling af basiske derivater af 1-aryl-2-oxo-2,4,5,6,7,7a-hexahydroindoler eller syreadditionssalte deraf.
DK138848C (da) Analogifremgangsmaade til fremstilling af phenylpropanolaminderivater eller syreadditionssalte deraf
DK138391C (da) Analogifremgangsmaade til fremstilling af n-(1'-allylpyrrolidinyl-2'-methyl)-2-methoxy-4,5-azimido-benzamid eller syreadditionssalte eller kvaternaere ammoniumsalte eller optisk aktive isomere deraf
DK138267B (da) Fremgangsmåde til fremstilling af 1,4-benzodiazepin-2-on-derivater eller syreadditionssalte deraf.
DK140838B (da) Analogifremgangsmaade til fremstilling af 6-eller 7-cyan-3-methylquinoxalin-2-carboxamid-1,4-dioxid-forbindelser eller syreadditionssalte deraf
DK134752C (da) Analogifremgangsmade til fremstilling af(+)-3r-n-monomethyl-amino-4c-phenyl-4t-ethoxycarbonyl-cyclohexen-(1)eller syreadditionssalte deraf